Cargando…
Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics
Breast cancer brain metastases remain a significant clinical problem. Chemotherapy is ineffective and a lack of treatment options result in poor patient outcomes. Targeted therapeutics have proven to be highly effective in primary breast cancer, but lack of molecular genomic characterization of meta...
Autores principales: | Bollig-Fischer, Aliccia, Michelhaugh, Sharon K., Wijesinghe, Priyanga, Dyson, Greg, Kruger, Adele, Palanisamy, Nallasivam, Choi, Lydia, Alosh, Baraa, Ali-Fehmi, Rouba, Mittal, Sandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546491/ https://www.ncbi.nlm.nih.gov/pubmed/25970776 |
Ejemplares similares
-
Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer
por: Bollig-Fischer, Aliccia, et al.
Publicado: (2021) -
Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity
por: Bao, Bin, et al.
Publicado: (2017) -
(–)–Epicatechin combined with 8 weeks of treadmill exercise is associated with increased angiogenic and mitochondrial signaling in mice
por: Lee, Icksoo, et al.
Publicado: (2015) -
Cytogenomic epileptology
por: Iourov, Ivan Y., et al.
Publicado: (2023) -
Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis
por: Wu, Richard Licheng, et al.
Publicado: (2015)